Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SER 109

X
Drug Profile

SER 109

Alternative Names: LIVE-BRPK - Seres Therapeutics; SER-109; VOWST

Latest Information Update: 07 Oct 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Seres Health
  • Developer Seres Therapeutics
  • Class Bacteria
  • Mechanism of Action Bacteria replacements; Gastrointestinal microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Clostridium difficile infections
  • New Molecular Entity No

Highest Development Phases

  • Marketed Clostridium difficile infections

Most Recent Events

  • 30 Sep 2024 Seres Therapeutics completes SER 109 asset sale to Nestle Health Science
  • 06 Jun 2024 Nestlé Health Science plans to complete the purchase of SER 109 from Seres Therapeutics by September 2024
  • 18 May 2024 Updated adverse event data from the phase III ECOSPOR IV trial in Clostridium difficile infections presented at the Digestive Disease Week (DDW-2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top